Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of SOX9 Expression in Colorectal Cancer

19 Nov 2008

Abstract excerpt

Our purpose was to investigate the role of SOX9, a novel downstream molecule of beta-catenin, in colorectal cancer. Expression of SOX9 and beta-catenin was detected by immunostaining, quantitative real-time reverse transcription-polymerase chain reaction (Q-PCR), and Western blot in colorectal cancer. The correlation between SOX9 or beta-catenin expression and clinicopathologic parameters was also analyzed....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Share to Genetic factors in colorectal cancer
Share to Sexual Differentiation and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19019766
DOI: 10.1309/ajcpw1w8gjbqgcni

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of SOX9 Expression in Colorectal CancerPMID 19019766Read ↗

SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 inductionSemantic proximity Read ↗

Oncogenicity of the Developmental Transcription Factor Sox9Semantic proximity Read ↗

Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma.Semantic proximity Read ↗

SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.Semantic proximity Read ↗

SOX9 expression predicts relapse of stage II colon cancer patientsSemantic proximity Read ↗

Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC PatientsSemantic proximity Read ↗

The dose-dependent effect of SOX9 and its incidence in colorectal cancer.Semantic proximity Read ↗

SOX9 promotes epithelial‑mesenchymal transition via the Hippo‑YAP signaling pathway in gastric carcinoma cellsSemantic proximity Read ↗

MiniSOX9, a dominant-negative variant in colon cancer cells.Semantic proximity Read ↗

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.Semantic proximity Read ↗

SOX9 directly regulates <i>IGFBP-4</i> in the intestinal epitheliumSemantic proximity Read ↗

Expression of the Carcinoembryonic Antigen Gene Is Inhibited by SOX9 in Human Colon Carcinoma CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.